<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01512381</url>
  </required_header>
  <id_info>
    <org_study_id>zubarev-vista-17-12</org_study_id>
    <nct_id>NCT01512381</nct_id>
  </id_info>
  <brief_title>Atrioventricular Node Ablation in Patients With Atrial Fibrillation and Moderate Chronic Heart Failure</brief_title>
  <acronym>VISTA</acronym>
  <official_title>Variant of Stimulation in Atrioventricular Node Ablation (VISTA) in Patients With Atrial Fibrillation and Moderate Chronic Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether cardiac resynchronization therapy (CRT) is
      superior to interventricular right ventricle (RV) septal pacing in respect of reverse
      remodeling (LV ESD) and morbidity in patients with less preserved (less than 45%) ejection
      fraction (EF), persistent/permanent atrial fibrillation (AF) who successfully received
      atrioventricular (AV) junction ablation ablation (100% pacemaker dependency)
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2010</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Left Ventricle End-Systolic Volume (LV ESV)</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of cardiovascular events (hospitalization for worsening heart failure)</measure>
    <time_frame>12 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Quality of Life (measured by Minnesota Living with Heart Failure Questionnaire)</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in NYHA functional class measured by peak V O2 oxygen consumption and distance of 6-minute walk test</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Echocardiographic indexes of LV remodeling</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>CRT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>pacemaker</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Implantation of CRT device</intervention_name>
    <description>RV lead of CRT system is implanted into the middle part of interventricular septum</description>
    <arm_group_label>CRT</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Implantation of conventional VVI(R) pacemaker</intervention_name>
    <description>RV lead is implanted into the middle part of interventricular septum</description>
    <arm_group_label>pacemaker</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age of 18-75 years

          -  CHF II-III NYHA

          -  Persistent/permanent AF requiring AV node ablation

          -  LVEF &lt; 45%

          -  Signed informed consent

          -  Able to complete all testing required by the clinical protocol

        Exclusion Criteria:

          -  Myocardial infarction or stroke less than 3 months prior to randomization

          -  Patients who require revascularization, radiofrequency ablation of pulmonary veins and
             substrate of AF

          -  The congenital and acquired heart diseases, LV aneurysm, which requires a surgical
             correction

          -  Active inflammatory and autoimmune diseases of a myocardium

          -  The thyrotoxicosis

          -  The diseases that limit life expectancy (cancer, tuberculosis, etc.)

          -  Contraindications to anticoagulants administration at CHADS2&gt; 2

          -  Uncompliant patients
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Almazov Federal Heart, Blood and Endocrinology Centre</name>
      <address>
        <city>Saint-Petersburg</city>
        <zip>197341</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dmitry S Lebedev, Prof</last_name>
      <phone>+78127023537</phone>
      <email>lebedevdmitry@mail.ru</email>
    </contact>
    <contact_backup>
      <last_name>Evgeny I Zubarev, MD</last_name>
      <phone>+78127023537</phone>
      <email>dr.zubarev@mail.ru</email>
    </contact_backup>
    <investigator>
      <last_name>Dmitry S Lebedev, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Evgeny I Zubarev, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Viktoria K Lebedeva, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 12, 2012</study_first_submitted>
  <study_first_submitted_qc>January 14, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 19, 2012</study_first_posted>
  <last_update_submitted>August 10, 2017</last_update_submitted>
  <last_update_submitted_qc>August 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>heart failure</keyword>
  <keyword>CRT</keyword>
  <keyword>atrial fibrillation</keyword>
  <keyword>AV junction ablation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

